The remaining studies also suggested a positive trend in early mAbs treatment for SOTR, generally showing lower incidences of severe COVID-19 outcomes compared to SOTR not treated with mAbs.
← all excerpts
Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future.
1
—
—